Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

BIO-TECHNE (TECH) Income from Continuing Operations: 2009-2025

Historic Income from Continuing Operations for BIO-TECHNE (TECH) over the last 17 years, with Jun 2025 value amounting to $22.2 million.

  • BIO-TECHNE's Income from Continuing Operations rose 13.65% to $38.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.8 million, marking a year-over-year decrease of 75.73%. This contributed to the annual value of $22.2 million for FY2025, which is 82.61% down from last year.
  • Per BIO-TECHNE's latest filing, its Income from Continuing Operations stood at $22.2 million for FY2025, which was down 82.61% from $127.9 million recorded in FY2024.
  • In the past 5 years, BIO-TECHNE's Income from Continuing Operations registered a high of $263.1 million during FY2022, and its lowest value of $22.2 million during FY2025.
  • In the last 3 years, BIO-TECHNE's Income from Continuing Operations had a median value of $127.9 million in 2024 and averaged $135.3 million.
  • In the last 5 years, BIO-TECHNE's Income from Continuing Operations surged by 135.81% in 2022 and then slumped by 82.61% in 2025.
  • Yearly analysis of 5 years shows BIO-TECHNE's Income from Continuing Operations stood at $111.6 million in 2021, then spiked by 135.81% to $263.1 million in 2022, then dropped by 2.83% to $255.6 million in 2023, then slumped by 49.95% to $127.9 million in 2024, then plummeted by 82.61% to $22.2 million in 2025.